AB vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 27, 2026
AB
45.9
AI Score
VS
CNS Wins
CNS
67.8
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | AB | CNS | Winner |
|---|---|---|---|
| Net Income | 76.58M | 156.96M | AB |
| ROA | 22.0% | 12.6% | CNS |
| Total Assets | 348.45M | 1.25B | AB |
Relative Price Performance (Last 90 Days)
AB 1M: -4.4%
· 3M: -5.0%
CNS 1M: -5.5%
· 3M: -8.1%
Current Technical Phase
AB
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 38
CNS
MarkdownSell / avoid
Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 36
Fundamentals Snapshot
| Metric | AB | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.3 | 18.3 |
| Trailing P/E | 10.4 | 22.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.4% | 0.1% |
| Gross Margin | 1.0% | 0.5% |
| Operating Margin | 1.0% | 0.3% |
| EPS | 3.36 | 3.25 |
| Dividend Yield | 0.10% | 0.04% |
Frequently Asked Questions
Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.